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ABSTRACT
Objective: To quantify data sharing trends and data
sharing policy compliance at the British Medical
Journal (BMJ) by analysing the rate of data sharing
practices, and investigate attitudes and examine
barriers towards data sharing.
Design: Observational study.
Setting: The BMJ research archive.
Participants: 160 randomly sampled BMJ research
articles from 2009 to 2015, excluding meta-analysis
and systematic reviews.
Main outcome measures: Percentages of research
articles that indicated the availability of their raw data
sets in their data sharing statements, and those that
easily made their data sets available on request.
Results: 3 articles contained the data in the article. 50
out of 157 (32%) remaining articles indicated the
availability of their data sets. 12 used publicly available
data and the remaining 38 were sent email requests to
access their data sets. Only 1 publicly available data set
could be accessed and only 6 out of 38 shared their
data via email. So only 7/157 research articles shared
their data sets, 4.5% (95% CI 1.8% to 9%). For 21
clinical trials bound by the BMJ data sharing policy,
the per cent shared was 24% (8% to 47%).
Conclusions: Despite the BMJ’s strong data sharing
policy, sharing rates are low. Possible explanations for
low data sharing rates could be: the wording of the
BMJ data sharing policy, which leaves room for
individual interpretation and possible loopholes; that
our email requests ended up in researchers spam
folders; and that researchers are not rewarded for
sharing their data. It might be time for a more effective
data sharing policy and better incentives for health and
medical researchers to share their data.
INTRODUCTION
Open data are deﬁned as ‘available, intelli-
gible, assessable and useable data’.1 The
practice of open data or ‘data sharing’ is the
term given to the exercise of making all raw
data fully and openly available, creating trans-
parency and ensuring reproducibility, and
driving further discovery by allowing new
knowledge to be generated in the context of
earlier discoveries.2–4 Though the concept of
data sharing has only recently been identi-
ﬁed as a subtheme of metaresearch,5 it was a
research topic 15 years ago when Reidpath
and Allotey conducted a prospective study to
examine data sharing among BMJ articles.
Only 1 out of 29 researchers contacted (3%)
made their data sets available. The reluc-
tance of researchers to make their data avail-
able raised questions about the validity of
their ﬁndings, and suggested the researchers
were potentially more concerned with not
losing an advantage than advancing science
through data sharing.6
The research climate in 2001 was signiﬁ-
cantly different to the current era, where
rapid technological advances are contributing
to what Bartling and Friesike7 refer to as the
second scientiﬁc revolution with terms such
as ‘data sharing’, ‘open data’, ‘open research’
and ‘Science 2.0’ proliferating in the scientiﬁc
discourse. Open data and data sharing are
now being considered as fundamental ele-
ments of the shift towards research that is veri-
ﬁable, reproducible and transparent.8
Given the many recent changes to research
publishing, it is ﬁtting to conduct a similar
study to Reidpath and Allotey’s. Our study
Strengths and limitations of this study
▪ Our study quantified data sharing among all
types of research articles published in the British
Medical Journal (BMJ) from 2009 to 2015.
▪ The BMJ data sharing policy specifically applies
to clinical trial data, but our study analysed data
sharing among all studies that have original raw
data.
▪ The sample size was 160 articles, which is rela-
tively small.
▪ The BMJ data sharing policy suggests using the
BMJ as a broker to negotiate data access;
however, we did not use this service given the
amount of time and resources it required both
on our part and on the BMJ’s.
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quantiﬁed data sharing trends at the BMJ from 2009 to
2015, paying particular attention to policy changes at
the journal that aimed to increase data sharing.
We selected the BMJ because it is an international
health and medical research journal leading the data
sharing movement. In March 2009, the BMJ introduced
the idea of a data sharing statement in research articles.
The purpose was to explain whether there were any add-
itional data available and how they could be accessed.9
The BMJ was among one of the ﬁrst medical journals to
introduce such a concept; a signiﬁcant milestone in the
data sharing movement that is gathering momentum in
health and medical research. In 2010, the BMJ crystal-
lised the data sharing statement into a policy.10 In 2012,
the BMJ introduced a stricter data sharing policy for
drugs and device trials: ‘from 1 January 2013, trials of
drugs and medical devices will be considered for publica-
tion only if the authors commit to making the relevant
anonymised patient-level data available on reasonable
request’.11 From 1 July 2015 the BMJ’s requirements for
data sharing extended to all submitted clinical trials, not
just those that tested drugs or devices.12 A number of jour-
nals now require authors share their data,13 14 either via a
public repository or making it freely available on request.
The success of these policies remain largely untested.15
Although the BMJ’s data sharing policy focuses on
trials, data sharing should ideally apply to all types of
research. This idea forms the basis of our study, which
not only examined clinical trials, but included all types
of studies with original raw data. The reason behind
our approach is that the BMJ is “…keen to maximise
the usefulness and usage of data and promote transpar-
ency, and to satisfy the requirements of the many
research funders that encourage or even mandate data
sharing”.16 From this statement, we deduce that the BMJ
supports research reproducibility and transparency of
research ﬁndings, which support high-quality research
and apply to all research data.
METHODS
Overview
A random sample of research papers published in the
BMJ were examined to observe the issues arising with
data sharing, including the point that was raised on a
recent BMJ podcast,17 namely, that researchers indicate
the availability of their data in order to pass the editorial
review, but fail to share when it is requested. We con-
tacted researchers who indicated in their data sharing
statements that they were willing to make their data sets
available. Our aims were to: (1) estimate the rate of data
sharing, and (2) examine the shared data sets by com-
paring them to the published ﬁndings to quantify the
integrity of the data sharing process.
Participants
A random number generator was used to select the
research papers (using Excel). We excluded studies
whose complete data were available in the article,
including systematic reviews and meta-analyses. All other
types of studies were included. Twenty BMJ research
papers were randomly sampled per year from 2009 to
2014. In 2015, we randomly selected 20 papers before a
major policy change on 1 July 2015 and 20 papers after.
The total sample size was 160. We did not use a formal
sample size calculation because they are often limited.18
Instead, the sample size was based on the practical con-
siderations of reading papers, contacting authors and
examining their data.
The setting of this study was the BMJ research archive.
All information required for data collection was publicly
available online. Data collection was started on 12
November 2015 and ended on 31 January 2016. The
ﬁrst author (AR-F) read the research papers and
extracted the details of authors. The following variables
were documented: type of study, data sharing statement
and data availability. The second author (AGB) inde-
pendently assessed the data sharing statements for 20
randomly selected articles. No disagreements were
found, meaning that there is a 90% probability that the
agreement between the two authors is over 90%.
Authors of articles who stated a willingness to share
their data were contacted via email. A de-identiﬁed copy
of our approach email to authors is included as an
online supplementary web appendix. Three research
articles had their data within the text of the article itself,
these researchers were not contacted, reducing the
sample size from 160 to 157.
Email requests for data were sent from 18 November
2015 to 16 December 2015. The 28 January 2016 was set
as the ﬁnal date for receiving data sets. A single
reminder was sent to researchers who made an initial
positive response but who did not send their data sets
even after 2 weeks. Alternative email addresses were only
sought when our original email bounced. A response
from authors was taken as consent to participate in the
study—all authors were informed about the ethical
approval of the study and the procedure of consent.
Some research articles indicated that their data were
available from external sources but were subject to add-
itional applications. We did not apply for these data sets
given the large amount of time it would take to apply,
and because there was no guarantee we would gain
access to the data.
Quantitative variables
We ﬁrst categorised each article into:
Data not available—research articles whose data sharing
statement was that ‘no additional data are available’;
Data available—research articles that indicated in their
data sharing statement that their data are available.
And then categorised those with data available into:
Data not available—research articles that did not make
their data sets available to our team on request and
research articles that had ‘publicly available data’ that we
could not locate;
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Data potentially available—research articles that indicated
that their data sets were available but they were subject
to forms and applications and research articles that men-
tioned that their data sets were publicly available but
they were not easily accessible and which also required
forms and applications;
Data easily available (received)—the research articles that
made their data set available to our team.
Statistical methods
We reported the per cent of data sharing and 95% CI.
We examined the sample sizes and variables in the
received data to verify that they matched the original
paper. We used logistic regression to examine a change
in data sharing over time using publication date as the
time variable. We used a log link in place of the logit, so
our results are prevalence ratios not ORs.19
RESULTS
Participants
Out of the 157 randomly sampled research articles, 50
indicated in various ways the availability of their raw
data. The numbers grouped by what was written in the
data sharing statements are given in table 1.
Thirty-eight emails were sent to researchers who indi-
cated in some way that their data sets were available. Of
the 38 authors who were emailed, only 16 of them
responded to our email, leaving 22 non-responses,
which were categorised as ‘data not available’. Six of the
16 responses provided their data sets to our team (1 of
which was a randomised clinical trial (RCT) but we
could not verify that the data shared matched the
article), these articles were categorised as ‘data easily
available (received)’. Eight of the 16 responses raised
caveats on request, 3 of which were categorised as ‘data
potentially available’ as they were subject to forms and
applications, and the remaining 5 were categorised as
‘data not available’. Two responses never followed
through to make their data available and were cate-
gorised as ‘data not available’.
Twelve research articles had data that were available
publicly or subject to forms: three provided external
links that were no longer functioning, and three pro-
vided generalised links with no clear indication of the
speciﬁc data set that was used for the purpose of the
study. These six articles were categorised as ‘data not
available’. Five of the 12 articles were subject to applica-
tion forms; these articles were categorised as ‘data
potentially available’. Only one of the ‘publicly available’
data sets was uploaded onto a public data depository,
Dryad.
Out of the 50 articles that had data available, 21 were
RCTs. One RCT data set was freely available on Dryad,
leaving 20 RCTs which were emailed to request their
data. Thirteen of the 20 did not respond to our email
and were categorised as ‘data not available’, 4/20 made
their data available (1 of which was unveriﬁable) an
overall sharing rate of 24% (8% to 47%). The remaining
3/7 responses raised caveats and did not make their
data available to our team.
A ﬂow chart of the data sharing results is shown in
ﬁgures 1 and 2 for RCTs which are bound by the BMJ
data sharing policy. The data sharing rates by BMJ policy
changes are in ﬁgure 3.
Main results
The total numbers were: 7/50 articles had ‘data easily
available (received)’, 35/50 articles were ‘data not avail-
able’ and 8/50 articles were ‘data potentially available’.
Six of the seven data sets contained data that matched
the article, with one data set unveriﬁable as it was difﬁ-
cult to navigate the data and no data dictionary was
provided.
The percentage of data easily available from the 157
articles was only 4.5% (95% CI 1.8% to 9%). One of the
shared data sets was not veriﬁable, so the actual data
sharing rate might be lower than 4.5%. A further eight
articles had data potentially available, so the data
sharing rate could be as high as 9.6% (5.5% to 15%).
For RCTs, 5/21 RCTs made their data sets easily avail-
able, a data sharing rate of 24% (95% CI 8% to 47%).
Table 1 Numbers of various data sharing statements for randomly selected British Medical Journal (BMJ) research articles
(2009–2015) that indicated the availability of their raw data
2009 2010 2011 2012 2013 2014
2015
(1)
2015
(2) Total
Additional data available from author 1 1 3 4 3 2 5 0 19
Reasonable requests for access to data can be made
to the authors
0 1 0 2 1 2 7 2 15
Data were available from external sources subject to
additional applications
0 1 0 1 0 1 3 2 8
Data publicly available 0 0 0 0 0 2 0 3 5
Data were available once they had completed all
planned analyses and published results
0 1 0 1 0 0 0 0 2
Data were available after 3 years, subject to a contract
and authors will examine requests
0 0 0 0 0 1 0 0 1
Total 1 4 3 8 4 8 15 7 50
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Sixteen of the 21 RCTs were categorised as ‘data not
available’, and 0/21 in ‘data potentially available’.
Twenty-nine of the 50 articles were not bound by the
policy but indicated data availability in their data sharing
statements, only 2 of which made their data available.
The sharing rate for those articles not bound by the BMJ
data sharing policy is: 2/29, 7% (95% CI 1% to 23%).
Authors’ responses to data sharing
The authors who made their data sets available did so
with positive and encouraging words. Here are a few
examples:
Good luck with your project, I am a ﬁrm supporter of
open access to data.
Thank you very much for you interest in our study. We
adhere the BMJ data sharing policy indeed. Please ﬁnd
attached the data ﬁles.
One researcher went so far as to offer to translate the
data set into English.
Eight out of 16 authors provided email responses that
were not consistent with their data sharing statements
and raised caveats, including the requirement for enter-
ing into contracts with their institutions; writing a
detailed plan indicating what we will do with their data;
potentially paying for their data; that their data were no
longer available as they are carrying out additional
studies and that their data were only available on their
own university premises. These hidden policies, con-
tracts, costs and rules were not included in their BMJ
data sharing statements. One researcher thought our
research question was not ‘a reasonable research ques-
tion’ and so refused to share their data.
Change over time
A logistic regression showed that there was a 26% increase
in the rate of ‘data shared’ for every additional year
between 2009 and 2015 (95% CI 13% to 43%), and a 40%
increase in the rate of ‘data promised’ for every additional
year between 2009 and 2015 (95% CI −4% to 131%).
DISCUSSION
Only 32% of research articles published indicated the
availability of their raw data. And then only 14% of those
approached made their data easily available, and just one
was freely accessible on Dryad. This gives an overall per
cent of only 4.5% of data sharing for research articles at
the BMJ, with a higher 24% data sharing rate among clin-
ical trials that are bound by the BMJ data sharing policy.
Interpretation
From the 50 out of 157 authors that indicated the avail-
ability of their raw data, less than half were clinical trials
Figure 1 Flow chart of the
randomly sampled BMJ research
articles showing the availability of
data. BMJ, British Medical
Journal.
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(21), and the rest were: cohort studies, cross-sectional
analyses, modelling studies, case–control studies, retro-
spective analyses and others. It is encouraging to note
that the majority of research articles that offered to
make their raw data available were not bound by the
data sharing policy that speciﬁcally applies to clinical
trials. Assessing compliance of the BMJ data sharing
policy was not the focus of our study as we were inter-
ested in all types of research articles. The easily available
data sharing rate for clinical trials was 24%, which is
higher than the rate for all articles types, but still low.
There are of course cases where ethical and legal con-
straints prevent data sharing, and we did not measure
these occurrences.
Though 50 out of 157 research articles indicated the
availability of their raw data, only 7 researchers easily
provided their data for this study. It seems data sharing
rates at the BMJ have only increased from 3% to 4.5% in
15 years, but with a 40% increase in the rate of ‘data
promised’ since 20096 demonstrating an increased com-
pliance with data sharing policies for publication pur-
poses, but not in practice.17
With regard to the caveats that were raised only after
we requested access to ‘available’ raw data, we recognise
that researchers have the right to set their own condi-
tions for data access, but none of these conditions were
mentioned in the data sharing statements. Ideally
authors should state all the conditions in their data
sharing statement, so as to clearly outline the procedures
for accessing their raw data. It should not take much
extra time to add this information to the data sharing
statement. If there are restrictions on data availability—
such as, home institution restrictions or other agree-
ments with companies—these restrictions should be
clearly outlined in the data sharing statement, an
example of which could read: ‘our university’s data
sharing policy is that data are only available at our insti-
tution’. Ideal data sharing is freely available, easily
accessible raw data that are downloadable from an
online data depository, such as Dryad.
Our ﬁndings are comparable to similar studies assessing
data sharing rates at Public Library of Science (PLoS) journals.
A study by Savage and Vickers20 in 2009 received only 1/
10 data sets (10%) that were requested, and a larger
sample of 441 biomedical journal articles published from
2000 to 2014 had a data sharing rate of 0%, although
these researchers only searched for freely available data
and did not email authors.5 It is evident that data sharing
is not common practice even among publishers with
strong data sharing policies such as the BMJ and PLoS.
The cultural shift towards more open data in health
and medical research is not as developed as the discip-
line of genomics. An empirical study conducted by Milia
et al21 in 2012 demonstrated that ‘the majority of
Figure 2 Flow chart of the
randomly sampled BMJ research
articles bound by the BMJ data
sharing policy, RCTs, showing
the availability of data. BMJ,
British Medical Journal; RCT,
randomised clinical trial.
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published data regarding human genetic variation are
made openly available to the scientiﬁc community’.
There are a few possible explanations for the low
data sharing rates at the BMJ. The wording of the BMJ
data sharing policy states that authors of all submitted
clinical trials, not just those that test drugs and devices,
commit to making the relevant anonymised patient-
level data available on reasonable request.12 Fiona
Godlee’s editorial post in 2012 explains ‘reasonable
request’ as:
“As for ‘reasonable request’, The BMJ is not in a pos-
ition to adjudicate, but we will expect requesters to
submit a protocol for their re-analysis to the authors and
to commit to making their results public. We will encour-
age those requesting data to send a rapid response to
thebmj.com, describing what they are looking for. If the
request is refused we will ask the authors of the paper to
explain why.”11
The interpretation of ‘reasonable request’ is left to
individual authors. What we thought as a ‘reasonable
Figure 3 Summary of data availability and actual data received for BMJ research articles grouped by year and in relation to
data sharing policy changes. BMJ, British Medical Journal; RCT, randomised clinical trial.
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request’ may not be by other researchers, and could be
behind the low data sharing rate. Some thought that the
purpose of our study was not worth their time and
resources, hence labelling our study in the category of
unreasonable requests. It is not the purpose of this paper
to convince the audience of the reasonability of our
study, rather to bring to the BMJ’s attention the ambiguity
created by the policy wording. With regard to submitting
a protocol, our email included all the procedures of our
examination of the data set for veriﬁcation. We did not
use the BMJ to broker access to papers on our behalf,
and the data sharing rate could be higher if we used this
route, although we note that this takes additional time
and effort on our behalf and staff at the BMJ.
There are other potential reasons for the low data
sharing rates. Given that 55% of the researchers con-
tacted via email did not respond, we could deduce that:
they never received our email due to out-dated email
addresses or spam ﬁlters, that researchers were too busy,
or that our request was simply ignored. We therefore rec-
ommend that multiple contacts are given, potentially
including other researchers or even Twitter accounts.
Non-response problems would be overcome by having
the data stored by a third party, such as Dryad, as recom-
mended by the BMJ.
Another possible barrier of data sharing is the lack of
rewards in the scientiﬁc community. Researchers who
participate in the culture of sharing should be sup-
ported and rewarded by the academic and research
career systems.22–24 The lack of incentives for data
sharing is a key barrier as researchers are often time
poor and many do not see the value of spending time
preparing their data or may be concerned about lengthy
follow-up questions. A recent study conducted by
Kidwell et al25 demonstrated that badges, developed by
the Centre of Open Science, were effective incentives
that increased data sharing rates. To encourage data
sharing in health and medical research, it might be
beneﬁcial to change the criteria by which scientists and
their teams are rewarded for their efforts by funding
agencies and institutions.26 Ioannidis and Khoury26
designed the ‘PQRST approach’ for rewarding research-
ers, where the ‘S’ stood for sharing of data, code and
protocols. To contribute to the adoption of a culture of
data sharing, in early 2016 the International Committee
of Medical Journal Editors (ICMJE) put together a pro-
posal outlining some requirements to help meet the
mandating of clinical trial data sharing worldwide.27
Limitations
The sample size of 160 is relatively small. However, the
CI for the rate of easily shared data are quite narrow
and the upper limit is below 10%.
Our data sharing rate could be increased by more
active chasing of researchers, yet, as Iqbal et al5 indi-
cated, ‘the yield would be uncertain, and personal com-
munications should not replace the lack of transparency
in the published scientiﬁc record’. As such, we did not
try to ﬁnd alternative email addresses for those research-
ers who did not respond (we did try to ﬁnd an alterna-
tive address if an email bounced), nor did we follow-up
on them. Also, we did not approach the journal to help
us negotiate access due to the amount of time and
resources such a task requires both on our part and the
BMJ’s for up to 160 papers.
We did not compare the characteristics of those who
did and did not share their data (eg, which country was
best/worst) as that was not one of our study aims.
Generalisability
We used a random sample of BMJ research papers and
only excluded meta-analyses and systematic reviews. Hence,
our results should be generalisable to the wider BMJ litera-
ture and potentially to other general medical journals.
CONCLUSION
As policies and procedures, rules and regulations that
promote and encourage data sharing become more
common, our study provides a glimpse into the reality of
data sharing practices among health and medical
researchers, using the BMJ as a case study. Has open data
arrived at the BMJ? We think not. With a data sharing
rate of only 4.5% among all studies and 24% among clin-
ical trials, there is clear room for improvement despite
the journal’s internationally leading stance on encour-
aging data sharing. Tighter data sharing policies and
better incentives for researchers to share their data might
be needed.
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